Peru DIGEMID registration DMDIV3841E

SARS-CoV-2 ANTIBODY TEST (COLLOIDAL GOLD IMMUNOCHROMATOGRAPHY), MARCA: LECCURATE®

Peru·IN VITRO MEDICAL DEVICE·BEIJING LEPU MEDICAL TECHNOLOGY CO., LTD.·Registered March 29, 2021

Device classification

Product Type: IN VITRO MEDICAL DEVICE

Registration information

Analysis ID: DMDIV3841E
Registration Date: March 29, 2021
Expiration Date: March 29, 2026
Creation Date: September 26, 2024

Manufacturer

Name: BEIJING LEPU MEDICAL TECHNOLOGY CO., LTD.

Authorized Representative

Name: MEDHEALTH PERU S.A.C.

About this record

Access comprehensive regulatory information for SARS-CoV-2 ANTIBODY TEST (COLLOIDAL GOLD IMMUNOCHROMATOGRAPHY), MARCA: LECCURATE® in the Peru medical device market through Pure Global AI's free database. This medical device is registered under DIGEMID ID DMDIV3841E and manufactured by BEIJING LEPU MEDICAL TECHNOLOGY CO., LTD.. The device was registered on March 29, 2021.

This page provides complete registration details including product type (IN VITRO MEDICAL DEVICE), manufacturer information, authorized representative details, and regulatory compliance data from the official Peru DIGEMID medical device database. Pure Global AI offers free access to Peru's complete medical device registry.